Home
PSTV
PSTV News

Latest PLUS THERAPEUTICS Inc. (PSTV) News on November 25, 2024

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

GlobeNewswire

3 days ago

Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

Argus Research

3 days ago

Daily – Vickers Top Insider Picks for 11/22/2024

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

GlobeNewswire

4 days ago

Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

Argus Research

4 days ago

Daily – Vickers Top Insider Picks for 11/21/2024

Argus Research

5 days ago

Daily – Vickers Top Insider Picks for 11/20/2024

Argus Research

6 days ago

Daily – Vickers Top Insider Picks for 11/19/2024

Argus Research

7 days ago

Daily – Vickers Top Insider Picks for 11/18/2024

Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

8 days ago

Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Argus Research

10 days ago

Daily – Vickers Top Insider Picks for 11/15/2024

Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

GuruFocus.com

10 days ago

Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

11 days ago

Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Argus Research

11 days ago

Daily – Vickers Top Insider Picks for 11/14/2024

ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates

Zacks

12 days ago

ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates

Argus Research

12 days ago

Daily – Vickers Top Insider Picks for 11/13/2024

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates

Zacks

13 days ago

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates

Argus Research

14 days ago

Daily – Vickers Top Insider Picks for 11/11/2024

Argus Research

17 days ago

Daily – Vickers Top Insider Picks for 11/08/2024

Argus Research

18 days ago

Daily – Vickers Top Insider Picks for 11/07/2024

MT Newswires

19 days ago

Plus Therapeutics, SpectronRx Collaborate to Manufacture Rhenium Obisbemeda Radiotherapy

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

GlobeNewswire

19 days ago

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Argus Research

19 days ago

Daily – Vickers Top Insider Picks for 11/06/2024

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024

GlobeNewswire

20 days ago

Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024

Argus Research

20 days ago

Daily – Vickers Top Insider Picks for 11/05/2024

Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates

Zacks

21 days ago

Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates

Argus Research

21 days ago

Daily – Vickers Top Insider Picks for 11/04/2024

MT Newswires

24 days ago

Plus Therapeutics Gets Additional Time to Regain Compliance With Nasdaq Listing Requirement

Argus Research

24 days ago

Daily – Vickers Top Insider Picks for 11/01/2024

Argus Research

25 days ago

Daily – Vickers Top Insider Picks for 10/31/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/30/2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

GlobeNewswire

a month ago

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/29/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/28/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/25/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/24/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/23/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/22/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/21/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/18/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/17/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/16/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/15/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/14/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 10/11/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/10/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/09/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/08/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/07/2024

MT Newswires

2 months ago

Plus Therapeutics Files $100 Million Mixed Shelf

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/04/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/03/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/02/2024

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting

GlobeNewswire

2 months ago

Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual Meeting

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/01/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/30/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/27/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/26/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/25/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/24/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/23/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/20/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/19/2024

Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting

GlobeNewswire

2 months ago

Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual Meeting

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 09/18/2024

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Plus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Plus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

3 months ago

Q2 2024 Plus Therapeutics Inc Earnings Call

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

3 months ago

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference

GlobeNewswire

3 months ago

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

GlobeNewswire

3 months ago

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024

GlobeNewswire

4 months ago

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference

GlobeNewswire

4 months ago

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

GlobeNewswire

5 months ago

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

6 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

6 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

6 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

6 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

6 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

6 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

6 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

6 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

MT Newswires

6 months ago

Plus Therapeutics to Receive $3.3 Million Advance Payment From CPRIT For Radiotherapeutic Development Program

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

GlobeNewswire

6 months ago

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

Plus Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

6 months ago

Plus Therapeutics Announces New Employment Inducement Grants

GuruFocus.com

6 months ago

Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

6 months ago

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024

GlobeNewswire

6 months ago

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial

GlobeNewswire

7 months ago

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

GlobeNewswire

7 months ago

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

Plus Therapeutics Announces Private Placement Financing of up to $18 Million

GlobeNewswire

7 months ago

Plus Therapeutics Announces Private Placement Financing of up to $18 Million

Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

Benzinga

7 months ago

Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense

GlobeNewswire

7 months ago

Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense

Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team

GlobeNewswire

8 months ago

Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference

GlobeNewswire

8 months ago

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

GlobeNewswire

8 months ago

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases

GlobeNewswire

8 months ago

Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript

Plus Therapeutics Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Plus Therapeutics Full Year 2023 Earnings: Beats Expectations

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Plus Therapeutics Inc Earnings Call

Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates

Zacks

9 months ago

Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates

Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

GlobeNewswire

9 months ago

Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Share on Social Networks: